Back

Different features of cardiac involvement in patients with AL vs. TTR amyloidosis

29 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Cardiac amyloidosis Cardiomyopathies ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Vladyslav Chubuchny

Toscana Gabriele Monasterio Foundation, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail
Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.
Mr M. Nicol (Paris, FR)
Abstract Slides
Presentation thumbnail
Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis
Presentation thumbnail
Predictors of progression of light-chain cardiac amyloidosis.
Doctor V. Rameev (Moscow, RU)
Abstract Slides
Presentation thumbnail
Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.
Professor T. Damy (Creteil, FR)
Abstract Slides
Presentation thumbnail
AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy
Associate Professor M. Alhamadsheh (Stockton, US)
Abstract

Access the full session

Session thumbnail
Cardiac amyloidosis

The Event

Event poster

ESC Congress 2017

29 August 2017 15:35 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms
29 August 2022
thumbnail
Webinar
New drugs in the treatment of amyloidosis
16 July 2025
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
31 August 2025
thumbnail
Congress Session
Amyloidosis – what to look for?
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources